| Year |
Citation |
Score |
| 2024 |
Chatterjee D, Svoboda RA, Huisman DH, Vieira HM, Rao C, Askew JA, Fisher KW, Lewis RE. KSR1 regulates small-cell lung carcinoma tumor initiation and therapy resistance. Biorxiv : the Preprint Server For Biology. PMID 38464216 DOI: 10.1101/2024.02.23.581815 |
0.534 |
|
| 2023 |
Daley BR, Vieira HM, Rao C, Hughes JM, Beckley ZM, Huisman DH, Chatterjee D, Sealover NE, Cox K, Askew JW, Svoboda RA, Fisher KW, Lewis RE, Kortum RL. SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status. Proceedings of the National Academy of Sciences of the United States of America. 120: e2313137120. PMID 37972068 DOI: 10.1073/pnas.2313137120 |
0.725 |
|
| 2023 |
Primeaux M, Liu X, Gowrikumar S, Fatima I, Fisher KW, Bastola D, Vecchio AJ, Singh AB, Dhawan P. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer. Cancer Letters. 216479. PMID 37924938 DOI: 10.1016/j.canlet.2023.216479 |
0.326 |
|
| 2022 |
Frodyma DE, Troia TC, Rao C, Svoboda RA, Berg JA, Shinde DD, Thomas VC, Lewis RE, Fisher KW. PGC-1β and ERRα Promote Glutamine Metabolism and Colorectal Cancer Survival via Transcriptional Upregulation of PCK2. Cancers. 14. PMID 36230802 DOI: 10.3390/cancers14194879 |
0.513 |
|
| 2021 |
Rao C, Frodyma DE, Southekal S, Svoboda RA, Black AR, Guda C, Mizutani T, Clevers H, Johnson KR, Fisher KW, Lewis RE. KSR1-and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition. Elife. 10. PMID 33970103 DOI: 10.7554/eLife.66608 |
0.516 |
|
| 2020 |
Rao C, Huisman DH, Vieira HM, Frodyma DE, Neilsen BK, Chakraborty B, Hight SK, White MA, Fisher KW, Lewis RE. A Gene Expression High-Throughput Screen (GE-HTS) for Coordinated Detection of Functionally Similar Effectors in Cancer. Cancers. 12. PMID 33120942 DOI: 10.3390/cancers12113143 |
0.543 |
|
| 2020 |
Neilsen BK, Kelly DL, Chakraborty B, Kim HS, White MA, Lewis RE, Fisher KW. High-throughput identification of protein functional similarities using a gene-expression-based siRNA screen. Scientific Data. 7: 27. PMID 31964871 DOI: 10.1038/s41597-020-0365-2 |
0.457 |
|
| 2019 |
McMillan EA, Kwon G, Clemenceau JR, Fisher KW, Vaden RM, Shaikh AF, Neilsen BK, Kelly D, Potts MB, Sung YJ, Mendiratta S, Hight SK, Lee Y, MacMillan JB, Lewis RE, et al. A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery. Cell Chemical Biology. PMID 31378711 DOI: 10.1016/J.Chembiol.2019.07.008 |
0.421 |
|
| 2019 |
Neilsen BK, Frodyma DE, McCall JL, Fisher KW, Lewis RE. ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells. Plos One. 14: e0209224. PMID 30629587 DOI: 10.1371/Journal.Pone.0209224 |
0.757 |
|
| 2018 |
Saeed O, Lopez-Beltran A, Fisher KW, Scarpelli M, Montironi R, Cimadamore A, Massari F, Santoni M, Cheng L. RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications. Journal of Clinical Pathology. PMID 30425122 DOI: 10.1136/jclinpath-2018-205471 |
0.35 |
|
| 2018 |
Neilsen BK, Chakraborty B, McCall JL, Frodyma DE, Sleightholm RL, Fisher KW, Lewis RE. WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage. Bmc Cancer. 18: 673. PMID 29925347 DOI: 10.1186/S12885-018-4580-6 |
0.729 |
|
| 2018 |
Das B, Neilsen BK, Fisher KW, Gehring D, Hu Y, Volle DJ, Kim HS, McCall JL, Kelly DL, MacMillan JB, White MA, Lewis RE. A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Scientific Reports. 8: 3770. PMID 29491475 DOI: 10.1038/S41598-018-22090-6 |
0.761 |
|
| 2017 |
Frodyma D, Neilsen B, Costanzo-Garvey D, Fisher K, Lewis R. Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras. F1000research. 6: 1621. PMID 29026529 DOI: 10.12688/F1000Research.11895.1 |
0.654 |
|
| 2017 |
Neilsen BK, Frodyma DE, Lewis RE, Fisher KW. KSR as a therapeutic target for Ras-dependent cancers. Expert Opinion On Therapeutic Targets. PMID 28333549 DOI: 10.1080/14728222.2017.1311325 |
0.582 |
|
| 2016 |
McCall JL, Gehring D, Clymer BK, Fisher KW, Das B, Kelly DL, Kim H, White MA, Lewis RE. KSR1 and EPHB4 regulate Myc and PGC1β to promote survival of human colon tumor cells. Molecular and Cellular Biology. PMID 27273865 DOI: 10.1128/Mcb.00087-16 |
0.768 |
|
| 2015 |
Fisher KW, Das B, Kim HS, Clymer BK, Gehring D, Smith D, Costanzo-Garvey D, Fernandez M, Brattain MG, Kelly D, MacMillan J, White MA, Lewis RE. AMPK promotes aberrant PGC1β expression to support human colon tumor cell survival. Molecular and Cellular Biology. PMID 26351140 DOI: 10.1128/Mcb.00528-15 |
0.752 |
|
| 2015 |
Kang HB, Fan J, Lin R, Elf S, Ji Q, Zhao L, Jin L, Seo JH, Shan C, Arbiser JL, Cohen C, Brat D, Miziorko HM, Kim E, Abdel-Wahab O, ... ... Fisher K, et al. Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Molecular Cell. PMID 26145173 DOI: 10.1016/J.Molcel.2015.05.037 |
0.413 |
|
| 2015 |
Fedorenko IV, Abel EV, Koomen JM, Fang B, Wood ER, Chen YA, Fisher KJ, Iyengar S, Dahlman KB, Wargo JA, Flaherty KT, Sosman JA, Sondak VK, Messina JL, Gibney GT, et al. Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells. Oncogene. PMID 26073081 DOI: 10.1038/Onc.2015.188 |
0.333 |
|
| 2014 |
Bai Y, Kim JY, Watters JM, Fang B, Kinose F, Song L, Koomen JM, Teer JK, Fisher K, Chen YA, Rix U, Haura EB. Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations. Cancer Research. 74: 7217-28. PMID 25348954 DOI: 10.1158/0008-5472.Can-14-0505 |
0.331 |
|
| 2014 |
Kortum RL, Fernandez MR, Costanzo-Garvey DL, Johnson HJ, Fisher KW, Volle DJ, Lewis RE. Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation. Molecular and Cellular Biology. 34: 3461-72. PMID 25002533 DOI: 10.1128/Mcb.01633-13 |
0.738 |
|
| 2014 |
Das B, Fisher K, Kim H, Volle DJ, Smith DR, Livergood RS, MacMillan J, White M, Lewis R. Abstract A07: Novel effectors of K-Ras-mediated and KSR1 dependent colon tumorigenesis Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-A07 |
0.656 |
|
| 2013 |
Potts MB, Kim HS, Fisher KW, Hu Y, Carrasco YP, Bulut GB, Ou YH, Herrera-Herrera ML, Cubillos F, Mendiratta S, Xiao G, Hofree M, Ideker T, Xie Y, Huang LJ, et al. Using functional signature ontology (FUSION) to identify mechanisms of action for natural products. Science Signaling. 6: ra90. PMID 24129700 DOI: 10.1126/Scisignal.2004657 |
0.449 |
|
| 2011 |
Fisher KW, Das B, Kortum RL, Chaika OV, Lewis RE. Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth. Molecular and Cellular Biology. 31: 2453-61. PMID 21518958 DOI: 10.1128/Mcb.05255-11 |
0.738 |
|
| 2011 |
Smift AL, Chen D, Pike LS, Fisher K, Winer M, Ferrick DA, Lewis RE, Wu M. KSR1, a molecular scaffold of the Ras-Raf-MEK-ERK kinase cascade that is necessary for H-Ras V12 -induced oncogenic transformation, is also required for uptake/consumption of glucose and glutamine in mouse embryonic fibroblasts F1000research. 2. DOI: 10.7490/F1000Research.782.1 |
0.58 |
|
| 2009 |
Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, Fernandez MR, Fisher K, Kortum RL, Hong EG, Jun JY, Ko HJ, Schreiner A, Volle DJ, Treece T, et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metabolism. 10: 366-78. PMID 19883615 DOI: 10.1016/J.Cmet.2009.09.010 |
0.723 |
|
| Show low-probability matches. |